A Biomonitoring Pilot Study in Workers from a Paints Production Plant Exposed to Pigment-Grade Titanium Dioxide (TiO
TiO2 powders
biological monitoring
exhaled breath condensate
occupational health
oxidative stress
paints production
Journal
Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637
Informations de publication
Date de publication:
31 Mar 2022
31 Mar 2022
Historique:
received:
20
02
2022
revised:
25
03
2022
accepted:
29
03
2022
entrez:
21
4
2022
pubmed:
22
4
2022
medline:
22
4
2022
Statut:
epublish
Résumé
Among particulate matter composing paints, titanium dioxide (TiO2) forms about 20% of the final suspension. Although TiO2 is broadly used in many applications, TiO2 powders represent an established respiratory hazard for workers with long-term exposure. In 35 workers of a paints production plant (15 exposed and 20 not exposed), we assessed pro-inflammatory cytokines (IL-1β, TNF-α, IL-10, IL-17), surfactant protein D (SP-D) and Krebs von den Lungen-6 glycoprotein (KL-6) in exhaled breath condensate (EBC). In urine samples, we measured 8-isoprostane (Isop) and Malondialdehyde (MDA) as biomarkers of oxidative stress, and Titanium (Ti-U) as a biomarker of exposure. Health status, habits and occupational history were recorded. Airborne respirable dusts and Ti were quantified. Particle number concentration and average diameter (nm) were detected by a NanoTracer™ monitoring device. Ti was measurable in filters collected at the respiratory breathing zone (0.11−0.44 µg/m3 8-h TWA). IL-1β and IL-10 values were significantly higher in exposed workers, whereas SP-D was significantly lower (p < 0.001). KL-6 was significantly higher in workers than in controls (p < 0.01). MDA levels were significantly increased in exposed workers and were positively correlated with Ti-U. Exposure to TiO2 in paint production is associated with the subtle alterations of lung pathobiology. These findings suggest the need for an integrated approach relying on both personal exposure and biomarker assessment to improve the hazard characterisation in occupational settings.
Identifiants
pubmed: 35448433
pii: toxics10040171
doi: 10.3390/toxics10040171
pmc: PMC9028136
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fondazione Cassa di Risparmio di Torino (CRT) and EU LIFE17 NanoExplore
ID : (ENV/GR/000285)
Références
Anal Biochem. 2017 May 1;524:13-30
pubmed: 27789233
Rapid Commun Mass Spectrom. 2011 Feb 28;25(4):463-8
pubmed: 21259353
Carcinogenesis. 1997 Feb;18(2):423-30
pubmed: 9054638
Chem Res Toxicol. 2012 Mar 19;25(3):646-55
pubmed: 22263745
J Am Chem Soc. 2009 Dec 2;131(47):17102-9
pubmed: 19899793
Toxicol Lett. 2018 Dec 1;298:112-124
pubmed: 29920308
Nanomaterials (Basel). 2020 Dec 06;10(12):
pubmed: 33291323
ACS Sustain Chem Eng. 2014;2(7):1691-1698
pubmed: 26753107
Ann Occup Hyg. 2015 Jul;59(6):669-80
pubmed: 25795003
Eur Respir J. 2005 Sep;26(3):523-48
pubmed: 16135737
Toxicol Sci. 2004 Feb;77(2):347-57
pubmed: 14600271
Ann Work Expo Health. 2017 Aug 1;61(7):749-758
pubmed: 28810681
Environ Res. 2015 Feb;137:141-6
pubmed: 25531819
Nanotoxicology. 2017 Feb;11(1):52-63
pubmed: 27855548
Nanotoxicology. 2012 Aug;6(5):453-71
pubmed: 21649461
Mediators Inflamm. 2017;2017:3908061
pubmed: 28316374
Int J Mol Sci. 2020 May 28;21(11):
pubmed: 32481492
Toxics. 2021 Aug 30;9(9):
pubmed: 34564355
Nanotoxicology. 2018 Mar;12(2):169-184
pubmed: 29324056
Int J Environ Res Public Health. 2020 Dec 05;17(23):
pubmed: 33291387
Cell Microbiol. 2007 Aug;9(8):1871-9
pubmed: 17490408
Am J Respir Crit Care Med. 1999 Feb;159(2):646-78
pubmed: 9927386
Nanoscale. 2013 Jul 21;5(14):6567-76
pubmed: 23760471
Part Fibre Toxicol. 2016 Feb 29;13:11
pubmed: 26926090
Am J Respir Cell Mol Biol. 1997 Oct;17(4):501-7
pubmed: 9376125
J Expo Sci Environ Epidemiol. 2013 May-Jun;23(3):322-7
pubmed: 23321859
J Expo Sci Environ Epidemiol. 2020 May;30(3):430-435
pubmed: 31420585
J Nanosci Nanotechnol. 2010 Dec;10(12):8575-83
pubmed: 21121368
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19449-54
pubmed: 20974980
J Breath Res. 2016 Jul 13;10(3):036006
pubmed: 27409350
Toxicol Sci. 2014 Sep;141(1):132-40
pubmed: 24924400
Int J Mol Sci. 2021 Apr 28;22(9):
pubmed: 33924924
J Epidemiol Community Health. 2018 Feb;72(2):148-153
pubmed: 29203525
Rev Med Interne. 2004 Jun;25(6):459-63
pubmed: 15158317
Toxicol Ind Health. 2015 Dec;31(12):1210-7
pubmed: 23771874
J Breath Res. 2016 Feb 01;10(1):016004
pubmed: 26828137
Occup Environ Med. 2016 Feb;73(2):110-8
pubmed: 26644454
Part Fibre Toxicol. 2009 Dec 17;6:33
pubmed: 20017923
Toxicol Lett. 2017 Jan 4;265:77-85
pubmed: 27884615
Part Fibre Toxicol. 2016 Jun 10;13(1):31
pubmed: 27286820
Int J Mol Sci. 2014 Jan 09;15(1):878-94
pubmed: 24413755
Toxicol Lett. 2020 Aug 1;328:19-27
pubmed: 32320775
Inhal Toxicol. 1999 Sep;11(9):837-54
pubmed: 10477445
Free Radic Biol Med. 2000 Feb 15;28(4):505-13
pubmed: 10719231
Nutr Metab Cardiovasc Dis. 2005 Aug;15(4):316-28
pubmed: 16054557
Environ Res. 2019 Jun;173:300-305
pubmed: 30939330
Am J Respir Crit Care Med. 2001 Sep 1;164(5):731-7
pubmed: 11549524
Int J Environ Res Public Health. 2021 Jan 07;18(2):
pubmed: 33430311
Toxicol Res (Camb). 2016 Apr 26;5(4):1122-1129
pubmed: 30090418
J Breath Res. 2015 Jul 14;9(3):036008
pubmed: 26172946